Previous close | 7.48 |
Open | 7.82 |
Bid | 6.10 |
Ask | 6.50 |
Strike | 260.00 |
Expiry date | 2023-10-20 |
Day's range | 6.00 - 7.82 |
Contract range | N/A |
Volume | |
Open interest | 120 |
GE Healthcare's potential windfall from Leqembi approval is being hampered by CMS coverage of PET scans.
With its stock down 14% over the past three months, it is easy to disregard Biogen (NASDAQ:BIIB). But if you pay close...
In the latest trading session, Biogen Inc. (BIIB) closed at $258.44, marking a -0.19% move from the previous day.